Eli Lilly CEO David Ricks asserted that the company’s views on the growing differences in drug prices between the US and Europe are not so different from the views of President Donald Trump, whose adm
The latest first-line multiple myeloma approval for Sanofi’s anti-CD38 product, Sarclisa (isatuximab), in the EU brings it a step closer to rival Johnson & Johnson’s Darzalex (daratumumab) in this
While undermining pandemic preparedness efforts, the Health and Human Services Department’s announcement that it would “wind down” messenger RNA vaccine projects related to influenza and COVID-19 will
While undermining pandemic preparedness efforts, the Department of Health and Human Services’ announcement that it would “wind down” messenger RNA vaccine projects related to influenza and COVID-19 wi